David R. Rubinow

2.0k total citations
31 papers, 1.4k citations indexed

About

David R. Rubinow is a scholar working on Public Health, Environmental and Occupational Health, Behavioral Neuroscience and Cellular and Molecular Neuroscience. According to data from OpenAlex, David R. Rubinow has authored 31 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Public Health, Environmental and Occupational Health, 7 papers in Behavioral Neuroscience and 6 papers in Cellular and Molecular Neuroscience. Recurrent topics in David R. Rubinow's work include Stress Responses and Cortisol (7 papers), Menstrual Health and Disorders (7 papers) and Epilepsy research and treatment (4 papers). David R. Rubinow is often cited by papers focused on Stress Responses and Cortisol (7 papers), Menstrual Health and Disorders (7 papers) and Epilepsy research and treatment (4 papers). David R. Rubinow collaborates with scholars based in United States, Czechia and Israel. David R. Rubinow's co-authors include Peter Roy‐Byrne, Peter J. Schmidt, Merry A. Danaceau, Miki Bloch, Robert C. Daly, Linda F. Adams, Robert M. Post, D. L. Gardner, Ellen Leibenluft and Nazli Haq and has published in prestigious journals such as New England Journal of Medicine, American Journal of Psychiatry and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

David R. Rubinow

30 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David R. Rubinow United States 20 368 354 353 236 228 31 1.4k
P W Gold United States 12 228 0.6× 109 0.3× 869 2.5× 315 1.3× 155 0.7× 14 1.6k
B J Carroll United States 17 171 0.5× 271 0.8× 381 1.1× 114 0.5× 51 0.2× 27 1.2k
J H Mendelson United States 24 330 0.9× 274 0.8× 122 0.3× 808 3.4× 435 1.9× 36 1.7k
A.M. Ghadirian Canada 19 183 0.5× 115 0.3× 246 0.7× 135 0.6× 75 0.3× 54 1.3k
E. Suy Belgium 26 252 0.7× 116 0.3× 1.7k 4.8× 231 1.0× 160 0.7× 48 2.8k
Joseph F. Mortola United States 31 673 1.8× 1.3k 3.7× 420 1.2× 86 0.4× 168 0.7× 51 3.0k
Catherine A. Roca United States 12 649 1.8× 540 1.5× 526 1.5× 69 0.3× 54 0.2× 18 1.4k
Astrid Bjørnebekk Norway 22 652 1.8× 75 0.2× 261 0.7× 305 1.3× 279 1.2× 49 1.6k
H. M. Shiers United Kingdom 8 267 0.7× 88 0.2× 561 1.6× 134 0.6× 92 0.4× 8 945
Molly M. Shores United States 21 1.2k 3.3× 125 0.4× 214 0.6× 90 0.4× 381 1.7× 30 1.9k

Countries citing papers authored by David R. Rubinow

Since Specialization
Citations

This map shows the geographic impact of David R. Rubinow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David R. Rubinow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David R. Rubinow more than expected).

Fields of papers citing papers by David R. Rubinow

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David R. Rubinow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David R. Rubinow. The network helps show where David R. Rubinow may publish in the future.

Co-authorship network of co-authors of David R. Rubinow

This figure shows the co-authorship network connecting the top 25 collaborators of David R. Rubinow. A scholar is included among the top collaborators of David R. Rubinow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David R. Rubinow. David R. Rubinow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rubinow, David R., et al.. (2019). Working memory of highly self‐critical men is impaired by failure. Applied Cognitive Psychology. 33(5). 958–963.
2.
Guerrieri, Gioia M., Pedro E. Martinez, Nazli Haq, et al.. (2014). Effects of physiologic testosterone therapy on quality of life, self-esteem, and mood in women with primary ovarian insufficiency. Menopause The Journal of The North American Menopause Society. 21(9). 952–961. 25 indexed citations
3.
Schmidt, Peter J., David R. Rubinow, & Carolyn A. Bondy. (2006). Adult women with Turner syndrome: A systematic evaluation of current and past psychiatric illness, social functioning, and self-esteem. International Congress Series. 1298. 100–107. 7 indexed citations
4.
Schmidt, Peter J., Robert C. Daly, Miki Bloch, et al.. (2005). Dehydroepiandrosterone Monotherapy in Midlife-Onset Major and Minor Depression. Archives of General Psychiatry. 62(2). 154–154. 195 indexed citations
5.
Daly, Robert C., Tung‐Ping Su, Peter J. Schmidt, et al.. (2001). Cerebrospinal Fluid and Behavioral Changes After Methyltestosterone Administration. Archives of General Psychiatry. 58(2). 172–172. 68 indexed citations
6.
Daly, Robert C., et al.. (2001). Effects of gonadal steroids on peripheral benzodiazepine receptor density in women with PMS and controls. Psychoneuroendocrinology. 26(6). 539–549. 6 indexed citations
7.
Bloch, Miki, Peter J. Schmidt, Merry A. Danaceau, Linda F. Adams, & David R. Rubinow. (1999). Dehydroepiandrosterone treatment of midlife dysthymia∗∗See accompanying Editorial, in this issue.. Biological Psychiatry. 45(12). 1533–1541. 144 indexed citations
8.
Pazzaglia, Peggy J., R M Post, David R. Rubinow, et al.. (1995). Cerebrospinal fluid total protein in patients with affective disorders. Psychiatry Research. 57(3). 259–266. 9 indexed citations
9.
Molchan, Susan, Brian Lawlor, James Hill, et al.. (1991). CSF monoamine metabolites and somatostatin in Alzheimer's disease and major depression. Biological Psychiatry. 29(11). 1110–1118. 46 indexed citations
10.
Cowdry, Rex W., et al.. (1991). Mood variability: a study of four groups. American Journal of Psychiatry. 148(11). 1505–1511. 119 indexed citations
11.
Scheinman, Pamela L., et al.. (1990). Acute depression from isotretinoin. Journal of the American Academy of Dermatology. 22(6). 1112–1114. 66 indexed citations
12.
Stein, Murray B., Paul J. Schmidt, David R. Rubinow, & T W Uhde. (1989). Panic disorder and the menstrual cycle: panic disorder patients, healthy control subjects, and patients with premenstrual syndrome. American Journal of Psychiatry. 146(10). 1299–1303. 43 indexed citations
13.
Rubinow, David R., et al.. (1989). Fluphenazine treatment reduces CSF somatostatin in patients with schizophrenia: Correlations with CSF HVA. Biological Psychiatry. 25(4). 431–439. 19 indexed citations
14.
Berrettini, Wade H., Göran Sedvall, John I. Nürnberger, et al.. (1988). Characteristics of cerebrospinal fluid neuropeptides relevant to clinical research. Psychiatry Research. 25(3). 349–359. 19 indexed citations
15.
Rubinow, David R., et al.. (1988). Neuropsychiatric consequences of AIDS. Annals of Neurology. 23(S1). S24–S26. 42 indexed citations
16.
Sunderland, Trey, David R. Rubinow, Pierre N. Tariot, et al.. (1987). CSF somatostatin in patients with Alzheimer's disease, older depressed patients, and age-matched control subjects. American Journal of Psychiatry. 144(10). 1313–1316. 43 indexed citations
17.
Rubinow, David R., Robert M. Post, Philip W. Gold, Naresh P. Emmanuel, & Seymour Reichlin. (1985). Effects of carbamazepine on cerebrospinal fluid somatostatin. Psychopharmacology. 85(2). 210–213. 29 indexed citations
18.
Rubinow, David R. & Peter Roy‐Byrne. (1984). Premenstrual syndromes: overview from a methodologic perspective. American Journal of Psychiatry. 141(2). 163–172. 188 indexed citations
19.
Rubinow, David R., et al.. (1983). Case 51-1982: Relapsing Polychondritis. New England Journal of Medicine. 308(19). 1165–1166. 2 indexed citations
20.
Giller, Earl L., Linda M. Bierer, David R. Rubinow, & John P. Docherty. (1980). Platelet MAO Vmax and Km in chronic schizophrenic subjects. American Journal of Psychiatry. 137(1). 97–98. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by P W Gold Breakdown of academic impact, for papers by B J Carroll Breakdown of academic impact, for papers by J H Mendelson Breakdown of academic impact, for papers by A.M. Ghadirian Breakdown of academic impact, for papers by E. Suy Breakdown of academic impact, for papers by Joseph F. Mortola Breakdown of academic impact, for papers by Catherine A. Roca Breakdown of academic impact, for papers by Astrid Bjørnebekk Breakdown of academic impact, for papers by H. M. Shiers Breakdown of academic impact, for papers by Molly M. Shores
Rankless by CCL
2026